Review of Hepatic Arterial Infusion Chemotherapy for Advanced Liver Cancer (2020–2025)

A figshare-administered review examines the role of hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma in the context of modern systemic therapies. The 593.7 KB collection of JPG files summarizes literature from 2020 to 2025, employing a PICO framework to assess efficacy and safety. It was last updated in April 2026 under a CC-BY-4.0 license.

Use Cases

• Summarizing evidence for HAIC efficacy and safety based on the described PICO framework literature review.
• Comparing regional HAIC approaches to systemic therapies for advanced HCC based on the review's thematic analysis.
• Identifying research gaps for HAIC standardization and trials in non-Asian populations based on the review's conclusions.

Strengths

• Focuses on a specific 2020–2025 time period for literature review.
• Explicitly employs a PICO framework for structured evidence assessment.
• Released under a permissive CC-BY-4.0 license for reuse.

Limitations

• The dataset is very small at 593.7 KB, indicating limited scope.
• Data consists of JPG images, not structured tabular or text data for direct analysis.
• Row count and column-level documentation are absent, requiring manual inspection of the image content.

Provenance

Source

figshare admin karger

Collection Method

Literature review employing a PICO framework.

Time Range

2020–2025

Freshness

Last updated 2026-04-09 07:55:12

Geography

Global focus, with noted popularity in East Asia.